Dexmedetomidine for Anesthesia

"After careful analysis, our team at Power has rated the safety of Dexmedetomidine a 3 due to Phase 4 trials that have already been conducted. This indicates that this treatment is approved and safe for use."

"This medical trial is accepting 25 minors aged between 3 and 18 who are willing to undertake anorectal manometry unaided by sedation (barring pre-med midazolam). The participants must be scheduled for upper or lower procedures at Boston Children's Hospital, consent to the study in writing, provide pregnancy testing results if female of reproductive age, and accept standard dexmedetomidine/propofol medication during their gastrointestinal procedure at the GPU."

"The information available on clinicaltrials.gov confirms that this trial is actively enrolling participants at present. It was initially posted in September 2021 and updated most recently, August 2022."

"At present, there are 110 active trials for Dexmedetomidine with 23 in their final Phase. Most of the clinical sites can be found in Karachi, Sindh; however, 207 locations globally are conducting research on Dexmedetomidine's efficacy and safety."

"As per the entry standards of this trial, minors aged 3 to 18 can be considered candidates."

"Affirmative. Clinicaltrials.gov conveys that this clinical trial, initially posted on September 14th 2021 has resumed its recruitment efforts of 25 patients from a single medical centre."

"Dexmedetomidine can be prescribed to relieve the symptoms of disease, ventilations, mechanical dysfunction and cyclic vomiting syndrome."